| pubmed-article:17175305 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17175305 | lifeskim:mentions | umls-concept:C0021081 | lld:lifeskim |
| pubmed-article:17175305 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:17175305 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:17175305 | lifeskim:mentions | umls-concept:C0205099 | lld:lifeskim |
| pubmed-article:17175305 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:17175305 | pubmed:dateCreated | 2006-12-18 | lld:pubmed |
| pubmed-article:17175305 | pubmed:abstractText | We examined short-term outcomes and posttransplant medical complications under three different immunosuppressive regimens at a single center. The study design was a randomized, prospective, open-label trial comparing a calcineurin inhibitor-free (CNI) protocol to standard triple therapy with tacrolimus, prednisone, and mycophenolate mofetil. They were also compared to a concurrent but nonrandomized third cohort treated with a prednisone-free protocol. All three groups had excellent early outcomes with no significant difference in patient or graft survival or biopsy-proven acute rejection. Serum creatinine was significantly lower in the CNI-free recipients. Lipid panels and posttransplant diabetes mellitus were significantly lower in the prednisone-free patients. Prednisone-free kidney transplant recipients have improved early glucose metabolism and hyperlipidemia compared to CNI-free or standard triple therapy recipients with comparable rejection and graft survival rates. | lld:pubmed |
| pubmed-article:17175305 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17175305 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17175305 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17175305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17175305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17175305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17175305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17175305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17175305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17175305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17175305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17175305 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17175305 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:17175305 | pubmed:issn | 0041-1345 | lld:pubmed |
| pubmed-article:17175305 | pubmed:author | pubmed-author:ShafferDD | lld:pubmed |
| pubmed-article:17175305 | pubmed:author | pubmed-author:HeldermanJ... | lld:pubmed |
| pubmed-article:17175305 | pubmed:author | pubmed-author:NylanderW AWA | lld:pubmed |
| pubmed-article:17175305 | pubmed:author | pubmed-author:FeurerII | lld:pubmed |
| pubmed-article:17175305 | pubmed:author | pubmed-author:LangoneA JAJ | lld:pubmed |
| pubmed-article:17175305 | pubmed:author | pubmed-author:KizilisikA... | lld:pubmed |
| pubmed-article:17175305 | pubmed:author | pubmed-author:SchaeferH MHM | lld:pubmed |
| pubmed-article:17175305 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17175305 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:17175305 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17175305 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17175305 | pubmed:pagination | 3466-7 | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:meshHeading | pubmed-meshheading:17175305... | lld:pubmed |
| pubmed-article:17175305 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17175305 | pubmed:articleTitle | Short-term results under three different immunosuppressive regimens at one center. | lld:pubmed |
| pubmed-article:17175305 | pubmed:affiliation | Division of Kidney and Pancreas Transplantation, Vanderbilt University Medical Center, Nashville, Tennessee 37232-4750, USA. | lld:pubmed |
| pubmed-article:17175305 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17175305 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
